Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial

Many patients with social anxiety disorder (SAD) experience inadequate symptom relief from available treatments. Ketamine is a potent N-methyl-D-aspartate receptor antagonist with a potentially novel mechanism of action for the treatment of anxiety disorders. Therefore, we conducted a double-blind,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuropsychopharmacology
Main Authors: Taylor, Jerome H, Landeros-Weisenberger, Angeli, Coughlin, Catherine, Mulqueen, Jilian, Johnson, Jessica A, Gabriel, Daniel, Reed, Margot O, Jakubovski, Ewgeni, Bloch, Michael H
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2018
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5729569/
https://ncbi.nlm.nih.gov/pubmed/28849779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2017.194
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki